Vinblastine in children and adolescents with high-risk anaplastic large-cell lymphoma: results of the randomized ALCL99-vinblastine trial
Le Deley, Marie-Cécile × Rosolen, Angelo Williams, Denise M Horibe, Keizo Wrobel, Grazyna Attarbaschi, Andishe Zsiros, Jozsef Uyttebroeck, Anne Marky, Ildiko M Lamant, Laurence Woessmann, Wilhelm Pillon, Marta Hobson, Rachel Mauguen, Audrey Reiter, Alfred Brugières, Laurence #
Grune & Stratton
Journal of Clinical Oncology vol:28 issue:25 pages:3987-93
The impact of adding vinblastine to a 4-month chemotherapy regimen, based on the Non-Hodgkin's Lymphoma Berlin-Frankfurt-Münster 90 protocol, in childhood high-risk anaplastic large-cell lymphoma (ALCL) was assessed.